A negative lymph node (NLN) may represent a stronger predictor for the overall survival (OS) rate of patients with esophageal squamous cell carcinoma (ESCC), when compared with a positive LN (PLN). The present study aimed to investigate which LN station, containing the NLN, was associated with OS rate. A retrospective review was conducted in 216 patients with ESCC and a forward stepwise Cox regression model analysis was used to assess the relationship between clinical parameters and OS rate. Patients were divided into subgroups according to the status of the LN at station 108. Survival analysis was performed using the Kaplan-Meier method. The ratio of albumin-to-globulin (AGR), and of lymphocytes to neutrophil granulocytes (LNR) in the subgroups were also investigated. Overall, 105p (the PLN number at station 105), 108p, 109p and 7p were confirmed to be risk factors for OS rate (all P<0.05). Conversely, 108n (the NLN number at station 108) was identified as a protective factor for OS rate [hazard ratio (HR) 0.457, P=0.001]. Survival analysis demonstrated that patients with an NLN identified at the station 108 had an improved OS rate compared with those with a PLN identified at station 108 (P=0.006). Patients with only an NLN identified at station 108 had the best OS rate among all the sub-groups examined, and the AGR of this group of patients was higher than those of the other groups. The LN status at station 108 may indicate the prognosis of patients with ESCC, and an NLN may reflect the reaction of the immune system to tumor metastasis in these patients.
Introduction
Esophageal squamous cell carcinoma (ESCC) is the principal pathological subtype of thoracic esophageal cancer reported in Asia in over the previous 30 years ( [1] [2] [3] . Although comprehensive therapeutic strategies, including surgery, radiation therapy and chemotherapy, have been applied, the overall survival (OS) rate of ESCC remains poor (4) . It has been widely recognized that lymph node metastasis (LNM) usually occurs in the early stages of disease, and serves an important role in the poor prognosis of patients with ESCC (5) .
Previous studies have published the distribution pattern of LNM and investigated the influence of the surgical removal of the LN on the prognosis of ESCC (6, 7) . The American Joint Committee on the Tumor Node Metastasis (TNM) system defined the N-staging classification using the number of positive LN (PLN) collected during surgery (8) . However, the number of negative LN (NLN) identified pathologically following surgery has been considered to be an even stronger predictor of OS rate in patients with ESCC (9) . The reason may be that the number of NLN could reflect the extent and quality of the individual surgery, and be considered a critical factor in the prognosis of patients with ESCC. To the best of our knowledge, it is unclear which LN station containing the NLN served a key role in the prognosis of patients with ESCC; therefore, improving the presently available knowledge would be helpful for the design of treatment plans for postoperative radiotherapy. Research had proven that radiotherapy serves a key role in decreasing the probability of local tumor recurrence following surgery, and in prolonging OS rate; however, there was an issue, in that the design of treatment plans for radiotherapy was based on the metastasis pattern of PLN, without considering the effect of NLN on the prognosis of patients (10, 11) . In other words, it was necessary to specify which LN station containing the NLN was associated with OS rate in patients with ESCC. Therefore, the present study aimed to investigate in which LN station the presence of NLN had a great impact on OS rate, for patients with middle and lower thoracic ESCC.
Patients and methods

Patient population.
A retrospective review was performed on the medical records of 216 patients with ESCC, who underwent esophagectomy and lymphadenectomy at Linyi People's Hospital, Shandong University (Linyi, China) between January 2009 and January 2013. The Institutional Review Board of Linyi People's Hospital approved the present study and all patients provided written informed consent. The criterion for patient selection were as follows: i) The patient received upper gastrointestinal endoscopy and upper gastrointestinal barium swallow, and the site of primary tumor was confirmed in the thoracic esophagus; ii) an ultrasound of the cervical region, computed tomography (CT) of chest and upper abdomen were performed to exclude distant metastasis of tumor; iii) the patient did not receive neo-adjuvant radiotherapy or chemotherapy prior to surgery; iv) the surgical specimen of the patient was identified as ESCC by two pathologists in the Department of Pathology in Linyi People's Hospital following surgery, and discussed uncertain samples until they reached an agreement; v) Tumor-free resection margin of the removed tissue were confirmed following surgery by a pathologist.
Treatment method. All patients underwent an extended esophagectomy with three-field or two-field LN dissection. Patients who underwent three-field LN dissection with tumor metastasis in the cervical region were considered based on an ultrasound or CT examination. The three-field LN dissections consisted of a collar neck incision, and a right thoracotomy and laparotomy, compared with the two-field LN dissection (including only a right thoracotomy and laparotomy). The dissection and labeling of LN stations was performed according to the system of the Japanese Society for Esophageal Diseases (12) , as presented in Table I . The surgical specimens and LN marked with site labels were collected at the end of surgery, and were evaluated by two specialist pathologists from the Department of Pathology in Linyi People's Hospital (Shangdong, China). All the specimens and LN were fixed in 10% formalin for 24 h under room temperature and embedded in paraffin, and then subjected to 0.5% concentration of hematoxylin and 2% concentration of eosin staining at room temperature for 0.5 h after sectioning (5-µm thick slices). Metastasis in the LN was identified following a consensus from the two pathologists using a light microscope with magnification x200, and the numbers of PLN and NLN in each LN station were recorded. The pathological tumor stage of each case was evaluated according to the American Joint Committee on Cancer (AJCC) TNM classification (7th edition) (8) . The post-operative treatment was selected according to the TNM stage of the tumor in each patient, and patients with an identical TNM stage received the same post-operative treatment. In another word, for example, patients with stage III of tumor were treated by chemo-and radiotherapy.
Follow-up. All patients underwent follow-up every 3 months for the first 2 years following surgical resection, and then every 6 months for the following 3 years. Upper gastrointestinal barium swallow, and CT or magnetic resonance imaging of the chest and upper abdomen, were used to evaluate the local recurrence and remote metastasis of the tumors. Patients who could not return to Linyi People's Hospital regularly were followed up by telephone. The final follow-up was conducted in January 2016. OS rate was evaluated as the time between surgery and patient mortality. The time of censoring was calculated from the date of surgery to the date of our last contact with the surviving patient.
Classification method of sub groups. Patients were initially divided into two groups, which included patients with PLN identified in the LN station 108, and patients with NLN identified in the LN station 108. Secondly, the patients were further divided into four groups, according to the status of the LN in the LN station 108, which can be described as follows: Group 1, patients whose PLN and NLN were identified in LN station 108 following surgery; Group 2, patients whose PLN were identified in LN station 108 following surgery; Group 3, patients whose NLN were identified in the LN station 108 following surgery; and Group 4, patients whose LN were not identified in the LN station 108 following surgery.
Ratio of albumin to globulin (AGR) and ratio of lymphocytes to neutrophils (LNR).
Information regarding albumin, globulin, lymphocytes and neutrophils in the blood was collected from the medical records of each patient. Four time points were selected to collect the information at follow-up: The first time point was one week prior to surgery (AGR1 and LNR1); the second was one week after surgery (AGR2 and LNR2); the third was two weeks after surgery (AGR3 and LNR3); and the fourth was one month after surgery (AGR4 and LNR4). The ratio of AGR was calculated as the quantity of albumin divided by the quantity of globulin in the blood. Accordingly, the ratio of LNR was calculated using the number of lymphocytes divided by the number of neutrophils in the blood. The AGR and LNR at the four time points previously mentioned were calculated and used for subsequent analysis between patient subgroups. The differences in the ratios were investigated among the four groups prior to and following surgery.
Statistical analysis. The data in the present study are presented as the mean ± standard deviation. The relationship between clinical parameters and the number of PLN or NLN were explored using the χ 2 test and a forward stepwise Cox regression model analysis was further used to evaluate the associations between the above parameters and prognosis. Survival analysis was performed using Kaplan-Meier method and the differences of survival time between patient subgroups were investigated by log rank test. All the statistical analyses were computed using Stata/MP 13 (Stata Corp LP, College Station, TX, USA) and P<0.05 was considered to indicate a statistically significant difference.
Results
Patient characteristics and OS rate.
The number of censored case in this study was 24 (11.9%), which was lower than the average level in clinical study (13) . Excluding the patients who failed to attend for follow-up (24 cases), the medical information of the remaining 192 patients who completed follow-up was retrospectively reviewed. The characteristics of patients are shown in Table II . LNM were identified in 100 of the 192 patients, and the mean number of PLN was 0.874 (SD, 1.046; range, 1-5; median, 1) while the mean number of NLN was 3.168 (SD, 1.319; range, 1-7; median, 3). In the group of patients without LNM, the mean number of NLN was 3.195 (SD, 1.297; range, 1-6; median, 3). The mean follow-up time was 27.2 months (SD, 18.8; range, 3-73 months; median, 24 months). On the basis of the analysis for the entire cohort (192 patients), the 1, 3 and 5-year survival rates were 72.9, 38.9 and 23.8%, respectively.
Association between the LN station containing the NLN and patient survival. In the univariate analysis of the association between patient clinicopathological features and the LN status, the tumor length, tumor differentiation, depth of tumor invasion, tumor site, nerve invasion and lymph vessel invasion were all risk factors for the number of PLN, while only lymph vessel invasion was identified as a risk factor for the number of NLN (Table II) . All possible risk factors were subsequently put into a stepwise Cox analysis model, and 108p (the PLN number in LN station 108) and 109p (the PLN number in LN station 109) were confirmed as independent prognostic factors for OS rate (Table III) . Conversely, 108n (the NLN number in LN station 108) was highlighted as a protective factor for OS rate. In the analysis of the association between 108n and tumor relapse, the former was proven to have statistical effect against the latter (Table IV) . (Fig. 1) .
Further comparative analysis confirmed the presence of significant differences in OS rate among the four groups. Group 3 had the best outcome with a mean OS time of 34.208 Change in AGR and LNR in the subgroups following surgery. The AGR and LNR of patients decreased following surgery in all except Group 2, for which insufficient information regarding the AGR and LNR was obtained (data not shown). At the initial diagnosis of the disease, the number of AGR was similar amongst the three groups. However, following the operation, the number of AGR in Group 3 was higher than that of any other group until three months later. Similarly, the number of LNR were similar to one another amongst the three groups prior to the operation, however, the number of LNR in Groups 3 was higher compared with the other two groups until two months later (Fig. 3) .
Discussion
Previous studies have demonstrated that a greater number of NLN identified during surgery indicated an improved OS rate (9, 14) . The underlying mechanism of the important role of NLN in prognosis remains uncertain. Interpreting this has led to two possible hypotheses (15, 16) .
The first hypothesis is 'stage migration'. The extent of lymphadenectomy is insufficient if only PLN are removed in ESCC. The N stage of a tumor can be precisely evaluated only when sufficient NLN and PLN are removed via lymphadenectomy; otherwise, late-stage ESCC may be erroneously classified as early-stage ESCC. The second hypothesis is that the collection of more NLN during surgery may decrease the false-negative error rate in the pathological examination of LN. Researchers have previously demonstrated that tumor metastasis may be present in NLN, as determined by immunohistochemical staining methods, which may explain the aforementioned false-negative error rate (17, 18) . Increased identification of NLN by a pathologist may decrease the possibility of an incorrect evaluation of the N stage of a tumor. Previous studies have stated that the site of LNM is a more important prognostic factor than the number of LNM, and it was necessary to clarify which LN station containing the NLN would most significantly influence the outcome of patients (19, 20) .
The present study identified that the presence of NLN in LN station 108 could significantly influence the outcomes of patients, on the basis of multivariate Cox regression analysis and survival analysis. Furthermore, patients had a better prognosis if only NLN were identified in LN station 108, and these patients were primarily in the early N stage, which supports the 'stage migration' theory. The present study also identified that the LN stations 107 and 7 were high-efficiency LN stations containing NLN in patients with ESCC at an early N stage, which was in accordance with our previously published results (21) .
As the LN station 108 was categorically removed in the lymphadenectomy, regardless of whether three-field or two-field LN dissection was performed, and was used to assess the prognosis of patients and/or the extent of lymphadenectomy. The present study demonstrated that patients with only NLN identified in LN station 108 had an improved prognosis when compared with the other subgroups, indicating it should be seriously considered whether postoperative radiation therapy or chemotherapy treatment is appropriate for this group of patients. On the other hand, since the extent of lymphadenectomy remains controversial at present, it was worth exploring whether this group of patients could benefit from surgery wherein more LNs are removed via lymphadenectomy (22, 23) . Although the mechanism underlying the prognostic role of NLN in LN station 108 is complex, it could be interpreted from interactions between the patient immune system and tumor metastasis. LN station 108 is the closest LN station to the esophagus, and may be the first station, or the foothold, for tumor metastasis (12) . Patients with only NLN identified in LN station 108 may be in a stable condition due to immune system resistance to tumor metastasis. Dynamic investigation of the change in AGR and LNR in the present study supported this assumption. AGR and LNR were higher in patients with NLN identified in LN station 108 than those with PLN identified in LN station 108, and the AGR was significantly higher in patients with only NLN identified in LN station 108 compared with those in the other groups. This was consistent with prior reports that AGR and LNR have a close association with the prognosis of patients (24) (25) (26) . Based on the results of the present study, the AGR may be a more reliable predictor of outcomes inpatients, compared with the LNR. The reason for this may be that AGR may provide a true reflection of the condition of a patient that the AGR provides the combined information of immune and nutritional situation of patients (27, 28) . According to previous studies, AGR was considered to be closely associated with the patient immune system, and may be used as an indicator of the immune condition of patients in the future (29, 30) . Based on the results of other reports, the change in LNR could reflect the T-cell-dependent immune response to a tumor (31, 32) . However, one previous study produced the opposite results (33) . The reason for this might be that LNR is less stable than AGR, which was confirmed in the present study. Based on the aforementioned results the LN status of LN station 108 has the potential to be used as an indicator for the selection of postoperative treatment. Chemo-radiotherapy would not be recommended for patients with only NLN identified in LN station 108, compared with the recommended treatment based on the tumor stage.
In the univariate analysis performed in the present study, the length of the tumor, tumor differentiation, depth of tumor invasion, tumor site, nerve invasion and lymph vessel invasion were risk factors for tumor metastasis, which was consistent with previous results (34) . However, only the parameter of lymph vessel invasion influenced the number of NLN, which supported the interpretation, that tumor metastasis usually occurs through the lymph vessels in ESCC. Multivariate analysis revealed that the presence of negative LN in LN station 108 served a key role in tumor relapse and patient outcome, which supported the survival analysis results of the present study. The 1-, 3-and 5-year survival rates of patients were similar to those in reports published previously, and therefore, the selection bias of patients could be ignored in this study (35) .
There were several limitations to this study. First, this study was not an example of large-scale research; however, the inclusion criterion was strict and the pathological type was limited to the thoracic squamous cell carcinoma in order to exclude confounders. Furthermore, the statistical results were cross-validated using several methods to avoid statistical bias. The present study has been completed according to the research plan supervised by the Linyi People's Hospital ethics committee (Linyi, China); however, another larger-scale study is currently being conducted. Additionally, the results of the present study could be repeated based on the preliminary analysis (data not shown), and due to the size limitation of the cohort, it was impossible to further investigate the influence of NLN on prognosis in the sub-groups classified by T stage or the type of LN dissection. As the number of patients with only PLN identified in the LN station 108 was small, classified as group 2 in this study, it was difficult to dynamically explore the LNR and AGR change patterns in this group. Secondly, the inclusion criteria of the patients did not set a threshold on the LN number removed in the surgery in this study. However, in the present study, the majority of cases experienced systematic lymphectomy. Furthermore, results without an artificial threshold for the LN number are more valuable for popularized application in the future. Thirdly, the site of 108 LN station was adjacent to the 105 LN station in anatomy, and it was even difficult for experienced surgeons to differentiate where the swollen and syncretic positive LN where located in some cases (36) . To combat this, the present study labeled the positive LN in this situation as 108P+105P.
To conclude, the results of this study demonstrated that the presence of NLN in LN station 108 could be used as a predictor of prognosis; it may also be used as an indicator to recommend the extent of LN dissection. A prospective study is required to explore whether the presence of NLN in LN station 108 may be used as an indicator for the selection of post-operative treatment, compared with the present method instructed by the TNM system, which neglected the reported impact of negative LN on the prognosis of patients. Although the present study preliminarily identified the potential underlying mechanisms and the key role of NLN in LN station 108 in prognosis, further research is still required in order to explore and validate these mechanisms. Our further test program includes two additional studies. The first one aims to demonstrate that the negative LN inside thoracic cavity serves an important role in the prognosis of patients using a larger scale of patients (which at the time of publication is ongoing, data not shown). The second study aims to explore whether the status of LN in station 108 serves a key role in patients with ESCC in a perspective study, and whether it may be used a marker to indicate the extent and efficacy of lymphadenectomy. Figure 3 . The change of LNR and AGR following surgery in subgroups. The rate of LNRs and AGRs were collected at four time points. LNR1 and AGR1 were obtained one week prior to surgical resection while LNR2 and AGR2, LNR3 and AGR3, and LNR4 and AGR4 were obtained at one week, two weeks and one month following surgery, respectively. (A) The LNR in all subgroups was decreased following surgery; however, the LNR in Group 4 and Group 3 were higher than Group 1. (B) The AGR also decreased after operation in all subgroups, but the level of AGR in Group 3 was consistently higher than those in other subgroups at the four examined time points. AGR, Ratio of albumin to globulin; LNR, ratio of lymphocytes to neutrophils.
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